|
||||||||
![]() |
||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The vector sequence has been compiled using the information from sequence databases, published literature, and other sources, together with partial sequences obtained by Evrogen. This vector has not been completely sequenced. |
|||||||||||||||||||||||||||||||||||||||||||||||||
![]() Download
|
| ||||||||||||||||||||||||||||||||||||||||||||||||
| Nhe I | Bgl II* | Sac I | Hind III | EcoR I | Sal I | Kpn I | Apa I* | BamH I | Age I | TurboGFP | |||||||||||||||||||
| Afe I | Xho I* | Pst I* | Sac II | Nco I* | |||||||||||||||||||||||||
| GCT | A.GC | G.CT | A.CCG.GAC.TC | A.GAT. | CT | C. | GAG. | CTC. | AAG.CTT. | C | GA.ATT. | C | TG.CA | G. | TCG.AC | G.GTA. | CC | G.C | GG. | G | CC.C | G | G.G | AT.CC | A.CCG.GT | C.GCC.A | CC. | ATG.G | AG.AGC |
* – not unique site.
pTurboGFP-dest1 is a mammalian expression vector encoding destabilized green fluorescent protein TurboGFP-dest1 (see reporter description). To generate TurboGFP-dest1 variant, residues 422-461 of mouse ornithine decarboxylase (MODC) were fused to the TurboGFP C-terminus. This MODC region contains a PEST amino acid sequence that targets the protein for degradation and provides for rapid protein turnover [Li et al., 1998]. TurboGFP-dest1 retains fluorescent properties of the native protein and has a half-life of approximately 1-1.5 hours, as measured by fluorescence intensity of cells treated with the protein synthesis inhibitor, cycloheximide.
pTurboGFP-dest1 carries synthetic version of the TurboGFP-dest1 gene which codon usage is optimized for high expression in mammalian cells (humanized) [Haas et al., 1996]. To increase mRNA translation efficiency, Kozak consensus translation initiation site is generated upstream of the TurboGFP-dest1 coding sequence [Kozak, 1987].
pTurboGFP-dest1 vector can be used to express TurboGFP-dest1 in eukaryotic (mammalian) cells. For example it can be used as a positive control with a pTurboGFP-PRL-dest1 promoterless vector (Cat.# FP518). The vector can be also used to generate destabilized TurboGFP-tagged fusion proteins. Multiple cloning site (MCS) is located upstream of TurboGFP-dest1 coding sequence.
The vector backbone contains immediate early promoter of cytomegalovirus (PCMV IE) for protein expression, SV40 origin for replication in mammalian cells expressing SV40 T-antigen, pUC origin of replication for propagation in
SV40 early promoter (PSV40) provides neomycin resistance gene (Neor) expression to select stably transfected eukaryotic cells using G418. Bacterial promoter (P) provides kanamycin resistance gene expression (Kanr) in
Generation of TurboGFP-dest1-tagged fusions
A localization signal or a gene of interest can be cloned into MCS of the vector. It will be expressed as a fusion to the TurboGFP-dest1 N-terminus when inserted in the same reading frame as TurboGFP and no in-frame stop codons are present. TurboGFP-dest1-tagged fusions retain fluorescent properties of the native protein allowing fusion localization in vivo. Unmodified vector will express TurboGFP-dest1 when transfected into eukaryotic (mammalian) cells.
Note: The plasmid DNA was isolated from dam+-methylated
Expression in mammalian cells
pTurboGFP-dest1 vector can be transfected into mammalian cells by any known transfection method. CMV promoter provides strong, constitutive expression of TurboGFP-dest1 or its fusions in eukaryotic cells. If required, stable transformants can be selected using G418 [Gorman, 1985].
Propagation in
Suitable host strains for propagation in
Location of features
PCMV IE: 1-589
Enhancer region: 59-465
TATA box: 554-560
Transcription start point: 583
MCS: 591-671
TurboGFP
Kozak consensus translation initiation site: 672-682
Start codon (ATG): 679-681
Last amino acid in TurboGFP: 1372-1374
Stop codon: 1510-1512
MODC PEST sequence: 1390-1512
SV40 early mRNA polyadenylation signal
Polyadenylation signals: 1667-1672 & 1696-1701
mRNA 3' ends: 1705 & 1717
f1 single-strand DNA origin: 1764-2219
Bacterial promoter for expression of Kanr gene
-35 region: 2281-2286
-10 region: 2304-2309
Transcription start point: 2316
SV40 origin of replication: 2560-2695
SV40 early promoter
Enhancer (72-bp tandem repeats): 2393-2464 & 2465-2536
21-bp repeats: 2540-2560, 2561-2581 & 2583-2603
Early promoter element: 2616-2622
Major transcription start points: 2612, 2650, 2656 & 2661
Kanamycin/neomycin resistance gene
Neomycin phosphotransferase coding sequences:
Start codon (ATG): 2744-2746
Stop codon: 3536-3538
G->A mutation to remove Pst I site: 2926
C->A (Arg to Ser) mutation to remove BssH II site: 3272
Herpes simplex virus (HSV) thymidine kinase (TK) polyadenylation signal
Polyadenylation signals: 3774-3779 & 3787-3792
pUC plasmid replication origin: 4123-4766
Evrogen Fluorescent Protein Products (the Products) are intended for research use only. The Products are covered by Evrogen Patents and/or Patent applications pending. By use of these Products, you accept the terms and conditions of the applicable Limited Use Label License.
The CMV promoter is covered under U.S. Patents 5,168,062 and 5,385,839, and its use is permitted for research purposes only. Any other use of the CMV promoter requires a license from the University of Iowa Research Foundation, 214 Technology Innovation Center, Iowa City, IA 52242.
|
Copyright 2002-2011 Evrogen. All rights reserved. Evrogen JSC, 16/10 Miklukho-Maklaya str., Moscow, Russia, Tel +7(495)988-4084, Fax +7(495)988-4085, e-mail:evrogen@evrogen.com |